All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Trade association.

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Income

$120,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

HOUSE OF REPRESENTATIVES
Natl Economic Council (NEC)
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 4370
PREVAIL Act
S 2220
PREVAIL Act

Lobbying activity 3

Health Issues

Issues relating to drug pricing proposals including implementation of the Inflation Reduction Act (P.L. 117-169); Rx oversight issues; PBM oversight issues.

Trade (domestic/foreign)

Issues related to Section 301 tariffs; Issues related to IP protection; Market access issues.

Issues related to patent reform legislation; H.R. 4370/S. 2220 - The PREVAIL Act (118th Congress).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.